ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+13.38%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$966M
AUM Growth
+$966M
(+25%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
13.53%
Top 10 Holdings %
Top 10 Hldgs %
53.71%
Holding
39
New
13
Increased
10
Reduced
5
Closed
11
Top Buys
| 1 |
Exact Sciences
EXAS
|
$48.3M |
| 2 |
West Pharmaceutical
WST
|
$47.4M |
| 3 |
Align Technology
ALGN
|
$46.6M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$32.3M |
| 5 |
Fortrea Holdings
FTRE
|
$31.8M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$49.1M |
| 2 |
Idexx Laboratories
IDXX
|
$42.2M |
| 3 |
Surgery Partners
SGRY
|
$33.4M |
| 4 |
Inspire Medical Systems
INSP
|
$30.5M |
| 5 |
Elanco Animal Health
ELAN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 97.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Acadia Healthcare
ACHC
$2.12B
| $71.5M | 7.33% | 902,813 +110,820 | +14% | +$8.78M |
|
2
DexCom
DXCM
$29.5B
| $65.4M | 6.7% | 471,631 +181,631 | +63% | +$25.2M |
|
3
Icon
ICLR
$13.8B
| $50.7M | 5.19% | 150,853 -21,822 | -13% | -$7.33M |
|
4
AbbVie
ABBV
$372B
| $50.3M | 5.15% | 276,098 +26,098 | +10% | +$4.75M |
|
5
Intuitive Surgical
ISRG
$170B
| $49.6M | 5.08% | 124,337 +4,337 | +4% | +$1.73M |
|
|
6
Exact Sciences
EXAS
$8.98B
| $48.3M | 4.95% | +700,000 | New | +$48.3M |
|
|
7
West Pharmaceutical
WST
$17.8B
| $47.4M | 4.85% | +119,736 | New | +$47.4M |
|
|
8
Align Technology
ALGN
$10.3B
| $46.6M | 4.77% | +141,958 | New | +$46.6M |
|
9
Illumina
ILMN
$15.8B
| $45.4M | 4.65% | 330,758 +110,758 | +50% | +$15.2M |
|
10
Bruker
BRKR
$5.16B
| $43.8M | 4.49% | 466,521 +16,521 | +4% | +$1.55M |
|
11
Glaukos
GKOS
$5.5B
| $40.5M | 4.15% | 429,525 +184,919 | +76% | +$17.4M |
|
12
Teva Pharmaceuticals
TEVA
$21.1B
| $39.1M | 4% | 2,769,864 +1,469,864 | +113% | +$20.7M |
|
13
Brookdale Senior Living
BKD
$1.83B
| $39M | 3.99% | 5,897,960 +1,038,353 | +21% | +$6.86M |
|
|
14
Apellis Pharmaceuticals
APLS
$3.48B
| $32.3M | 3.31% | +550,000 | New | +$32.3M |
|
|
15
Fortrea Holdings
FTRE
$894M
| $31.8M | 3.25% | +791,233 | New | +$31.8M |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $30.3M | 3.11% | +220,000 | New | +$30.3M |
|
17
Avantor
AVTR
$9.18B
| $29.4M | 3.01% | +1,150,000 | New | +$29.4M |
|
|
SWAV
18
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $26M | 2.66% | +79,736 | New | +$26M |
|
19
Schrodinger
SDGR
$1.44B
| $23.3M | 2.39% | 863,323 +394,738 | +84% | +$10.7M |
|
20
Syndax Pharmaceuticals
SNDX
$1.41B
| $23.2M | 2.37% | +973,057 | New | +$23.2M |
|
21
SPDR S&P Biotech ETF
XBI
$5.07B
| $21.5M | 2.2% | +226,066 | New | +$21.5M |
|
|
22
Elanco Animal Health
ELAN
$9.12B
| $21.1M | 2.16% | 1,297,132 -1,702,868 | -57% | -$27.7M |
|
23
Cytokinetics
CYTK
$4.23B
| $21M | 2.15% | +300,000 | New | +$21M |
|
24
McKesson
MCK
$85.4B
| $20.1M | 2.06% | 37,419 -42,581 | -53% | -$22.9M |
|
25
Oscar Health
OSCR
$4.31B
| $19.8M | 2.03% | 1,334,503 -718,048 | -35% | -$10.7M |
|